Allergy/Imm Medical News about vaccine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pneumococcal Polysaccharide Protein D-Conjugate Vaccine (Synflorix(TM); PHiD-CV)
Pediatric Drugs, 09/10/09

Croxtall JD et al. – 11Pn–PD, an 11–valent prototype of PHiD–CV, demonstrated protection against episodes of acute otitis media (AOM) caused by S. pneumoniae and NTHi in infants aged <27 months. The first occurrence of an episode of AOM caused by pneumococcal vaccine serotypes was reduced by 52.6% in 11Pn–PD vaccinees compared with recipients of a control vaccine.

<< Previous
DNA vaccine manufacture: scale and quality

Next >>
Conference Scene - Active immunotherapeutics forum: meeting...